Biogen, Inc. (BIIB)

174.80 +4.89 (+2.88%) USD  |  NASDAQ  |  Dec 19, 16:00
176.00 +1.20 (+0.69%) After-Hours: 20:00
More

Biogen Unrealized Gain (Loss) on Investment Securities (Annual Per Share)

Unrealized Gain (Loss) on Investment Securities (Annual Per Share) Chart

View Unrealized Gain (Loss) on Investment Securities (Annual Per Share) for BIIB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Unrealized Gain (Loss) on Investment Securities (Annual Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Unrealized Gain (Loss) on Investment Securities (Annual Per Share) Range, Past 5 Years

View Unrealized Gain (Loss) on Investment Securities (Annual Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Unrealized Gain (Loss) on Investment Securities (Annual Per Share) Benchmarks

View Unrealized Gain (Loss) on Investment Securities (Annual Per Share) Benchmarks
Start Trial
Amgen, Inc. Upgrade
Eli Lilly & Co. Upgrade
Merck & Co., Inc. Upgrade
Pfizer Inc. Upgrade
Stoke Therapeutics, Inc. Upgrade